Protecting Our Infants Act of 2015 2015-09-08 Passed House without amendment (This measure has not been amended since it was introduced. The summary has been expanded because action occurred on the measure.)

Protecting Our Infants Act of 2015

(Sec. 3) This bill requires the Agency for Healthcare Research and Quality to report on prenatal opioid abuse and neonatal abstinence syndrome (symptoms of withdrawal in a newborn). (An opioid is a drug with effects similar to opium, such as heroin or certain pain medications.) The report must include:

  • an assessment of existing research on neonatal abstinence syndrome;
  • an evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age;
  • an evaluation of treatment for pregnant women with opioid use disorders and infants with neonatal abstinence syndrome; and
  • recommendations on preventing, identifying, and treating opioid dependency in women and neonatal abstinence syndrome.

(Sec. 4) The Department of Health and Human Services must review its activities related to prenatal opioid use and neonatal abstinence syndrome and develop a strategy to address gaps in research and programs.

(Sec. 5) The Centers for Disease Control and Prevention must provide technical assistance to states to improve neonatal abstinence syndrome surveillance and make surveillance data publicly available.]]> 2015-03-19 Introduced in House Protecting Our Infants Act of 2015

This bill requires the Agency for Healthcare Research and Quality to report on prenatal opioid abuse and neonatal abstinence syndrome (symptoms of withdrawal in a newborn). (An opioid is a drug with effects similar to opium, such as heroin or certain pain medications.) The report must include:

  • an assessment of existing research on neonatal abstinence syndrome;
  • an evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age;
  • an evaluation of treatment for pregnant women with opioid use disorders and infants with neonatal abstinence syndrome; and
  • recommendations on preventing, identifying, and treating opioid dependency in women and neonatal abstinence syndrome.

The Department of Health and Human Services must review its activities related to prenatal opioid use and neonatal abstinence syndrome and develop a strategy to address gaps in research and programs.

The Centers for Disease Control and Prevention must provide technical assistance to states to improve neonatal abstinence syndrome surveillance and make surveillance data publicly available.]]> text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.